Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04419584
PHASE2/PHASE3

Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

The study aims to evaluate the clinical efficacy and safety of the modified Qing-Ying Decoction (mQYD) for the treatment of subacute and chronic atopic dermatitis (AD) in children when compared to the placebo control through examining the clinical symptoms, quality of life, gut microbiome, and Chinese medicine body constitution. This is a parallel, randomized, placebo-controlled, double-blind clinical trial. Eligible subjects will be randomly allocated to receive oral mQYD granules or it's placebo granules. Subjects will have 12-week of treatment, and then a 4-week follow-up.

Official title: A Randomized Placebo-Controlled Clinical Trial of an Innovative Herbal Formula for Atopic Dermatitis in Children: Evaluations of Modified Qing-Ying Decoction on Efficacy and Gut Microbiome

Key Details

Gender

All

Age Range

4 Years - 17 Years

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2020-09-10

Completion Date

2027-08

Last Updated

2026-07-30

Healthy Volunteers

No

Interventions

DRUG

Modified Qing-Ying Decoction

Herbal granules

DRUG

Identical looking placebo

Placebo granules

Locations (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong